Pfizer co-manufacturer BioNTech on Friday stated that it can tweak and launch a new updated version of its COVID-19 mRNA vaccine in just about 100 days if the newly detected 'Omicron' variant of the novel coronavirus spreading in southern Africa is capable of evading the jabs’ protection and...
www.republicworld.com